2 ms·
It'd be great if something as simple in mechanism and production as vaccination and vitamin D turned out to be the key to longevity. I tend to doubt it, though.
by ceejayoz 4y ago
It'd be great if something as simple in mechanism and production as vaccination and vitamin D turned out to be the key to longevity. I tend to doubt it, though.
I get a med that's $18k every three months, for a mililiter of fluid. I wouldn't have a hope of paying for that without health insurance, and I'd expect health insurers to be resistant to covering mega-expensive life extension therapies.
- inglor_cz 4y agoIs your disease uncommon? Generally, the more common diseases are cheaper to treat, because the burden of development, IP etc. gets spread across more people. Medications for ubiquitous stuff such as high blood pressure tend to be comparably cheap, unless they are a fresh novelty. And aging is even more widespread than HBP.
- ceejayoz 4y ago> Is your disease uncommon? Estimated at 2-3% of the world population, so 100M+ people.
- inglor_cz 4y agoSo is the treatment something highly unusual? I am sorry to be prying such information out of you, but things with such a cost label tend to be very high-tech (e.g. tumor-invading lymphocytes etc. that need to be cultivated for each patient separately, which cannot possibly be cheap).
- ceejayoz 4y agoIt's a monoclonal antibody. I suspect it'll look cheap in comparison to life extension treatments.
- jjk166 4y agoThat's because monoclonal antibodies are targeted to a very specific protein. Polyclonal antibodies which can be used more generally are much cheaper. You're paying for the purity, not the substance.